INR 638.45
(-0.98%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.08 Billion INR | 2.73% |
2022 | 1.05 Billion INR | 20.4% |
2021 | 873.31 Million INR | 25.19% |
2020 | 697.57 Million INR | 23.58% |
2019 | 564.45 Million INR | 30.59% |
2018 | 432.22 Million INR | 134.83% |
2017 | 184.06 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 294.03 Million INR | 7.82% |
2024 Q2 | 601.54 Million INR | 21.5% |
2023 Q2 | 506.85 Million INR | 14.51% |
2023 Q1 | 442.64 Million INR | 390.69% |
2023 Q4 | 272.71 Million INR | -43.1% |
2023 FY | 1.08 Billion INR | 2.73% |
2023 Q3 | 479.24 Million INR | -5.45% |
2022 Q4 | -152.27 Million INR | -135.66% |
2022 Q3 | 426.98 Million INR | 7.58% |
2022 Q2 | 396.91 Million INR | 4.5% |
2022 Q1 | 379.81 Million INR | 823.03% |
2022 FY | 1.05 Billion INR | 20.4% |
2021 Q1 | 243.99 Million INR | 75.77% |
2021 FY | 873.31 Million INR | 25.19% |
2021 Q4 | -52.53 Million INR | -113.32% |
2021 Q3 | 394.31 Million INR | 205.08% |
2021 Q2 | 129.25 Million INR | -47.03% |
2020 Q3 | 268.98 Million INR | 0.0% |
2020 FY | 697.57 Million INR | 23.58% |
2020 Q4 | 138.81 Million INR | -48.39% |
2019 FY | 564.45 Million INR | 30.59% |
2018 FY | 432.22 Million INR | 134.83% |
2017 FY | 184.06 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.24 Million INR | -87008.871% |
Biocon Limited | 40.9 Billion INR | 97.359% |
Blue Jet Healthcare Limited | 531.85 Million INR | -103.093% |
Concord Biotech Limited | 1.45 Billion INR | 26.002% |
Dishman Carbogen Amcis Limited | 5.14 Billion INR | 79.016% |
FERMENTA BIOTECH LIMITED | 754.2 Million INR | -43.216% |
GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -287940.0% |
Lyka Labs Limited | 599.4 Million INR | -80.203% |
Panacea Biotec Limited | 1.99 Billion INR | 45.868% |
SAMSRITA LABS LIMITED | 1.49 Million INR | -72035.998% |
Servoteach Industries Limited | 785.00 INR | -137598626.115% |
SMS Lifesciences India Limited | 602.96 Million INR | -79.139% |
Syngene International Limited | 5.99 Billion INR | 81.982% |
TAKE Solutions Limited | 396.91 Million INR | -172.14% |
Titan Biotech Limited | 117.05 Million INR | -822.756% |
Transgene Biotek Limited | 5.39 Million INR | -19913.897% |
Vanta Bioscience Limited | 38.95 Million INR | -2672.601% |